{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-004651","form_type":"8-K","ticker":"NXTC","cik":"0001661059","company_name":"NextCure, Inc.","filed_at":"2025-04-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.244846+00:00","generated_at":"2026-05-23T17:17:41.875186+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"low","headline":"NextCure updates corporate presentation on LNCB74 trial; no specific data disclosed","bullets":["Updated presentation for LNCB74, a clinical-stage candidate, furnished on April 10, 2025.","Company engaging with investment community referencing updated materials.","No new clinical data, enrollment figures, or milestones provided in the filing or exhibit."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-004651","json":"https://secwatch.observer/filing/0001558370-25-004651.json","markdown":"https://secwatch.observer/filing/0001558370-25-004651.md","text":"https://secwatch.observer/filing/0001558370-25-004651.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661059/000155837025004651/0001558370-25-004651-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661059/000155837025004651/nxtc-20250410x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T17:17:41.875186+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}